Back
Replimune Group, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
37
REPL
Replimune Group, Inc.
Last Price:
$8.23
Seasonality Move:
-12.9%
7 Day Trial
ALL ACCESS PASS
$
7
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atReplimune Group, Inc. Stock Forecast
-
Over the next 52 weeks, Replimune Group, Inc. has on average historically risen by 19.4% based on the past 7 years of stock performance.
-
Replimune Group, Inc. has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
-
Is Replimune Group, Inc. Stock Undervalued?The current Replimune Group, Inc. [REPL] share price is $8.92. The Score for REPL is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
REPL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Replimune Group, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Replimune Group, Inc. has on average historically risen by 19.4% based on the past 7 years of stock performance.
Replimune Group, Inc. Stock Rating
Sell
37
Replimune Group, Inc. (REPL)
is a Sell
Is Replimune Group, Inc. overpriced?
-
Replimune Group, Inc. has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Replimune Group, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
replimune.com
52-Week Data
52-Week High:
14.80
52-Week Low:
2.68
Prediction Charts
Market Cap:
699.7M
Price in USD:
8.92
Volume:
844.6K
Beta:
1.62
Technical Analysis
SMA50:
9.53
SMA100:
7.45
SMA200:
7.96
52-Wk Change:
-20.36%
Stock Predictions
-
Is Replimune Group, Inc. stock public?Yes, Replimune Group, Inc. is a publicly traded company.
-
What is the Replimune Group, Inc. stock quote today?The Replimune Group, Inc. stock price is 8.92 USD today.
-
How to buy Replimune Group, Inc. stock online?You can buy Replimune Group, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-17 | 9.60 | 9.66 | 9.82 | 9.50 |
| Dec-18 | 9.80 | 9.69 | 9.96 | 9.57 |
| Dec-19 | 9.73 | 9.88 | 10.14 | 9.68 |
| Dec-22 | 9.87 | 9.93 | 10.20 | 9.80 |
| Dec-23 | 9.92 | 9.72 | 9.99 | 9.67 |
| Dec-24 | 9.95 | 10.09 | 10.27 | 9.84 |
| Dec-26 | 9.99 | 9.96 | 10.05 | 9.78 |
| Dec-29 | 9.84 | 9.76 | 10.05 | 9.71 |
| Dec-30 | 9.75 | 9.82 | 9.98 | 9.70 |
| Dec-31 | 9.81 | 9.72 | 9.99 | 9.70 |
| Jan-2 | 9.77 | 8.90 | 9.77 | 8.81 |
| Jan-5 | 8.80 | 8.42 | 8.88 | 8.23 |
| Jan-6 | 8.36 | 8.45 | 8.55 | 8.31 |
| Jan-7 | 8.46 | 8.92 | 9.41 | 8.45 |
Replimune Group, Inc. Earnings
Replimune Group, Inc. Earnings Report: Per Share Replimune Group, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Replimune Group, Inc. Forecast Revenue Growth
Replimune Group, Inc. Stock Analysis: Historical quarterly revenues per share for Replimune Group, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.56 per share, and an increase next year of $1.31 per share.
* Replimune Group, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.